Richard Knostman

Biography

From 2001 until joining Carticept in 2005, Rick was the Vice President, Operations for Proxima Therapeutics, Inc., a medical device company that developed and marketed innovative local radiation delivery systems for the treatment of solid cancerous tumors. Proxima was acquired by Cytyc Corporation in March 2005 for approximately $187 million. Prior to joining Proxima, he served as Division Vice President of Operations for Bard Access Systems, the world's leading manufacturer of vascular access catheters and ports and a division of C.R. Bard, Inc. Prior to his position with Bard, he was Vice President of Operations for Gesco International, a division of MedChem Products that was acquired by Bard in 1996. Rick also worked at Baxter Healthcare Corporation for 17 years, serving in positions that included plant manager, division planning manager and production manager. An inventor on several patents related to Carticept's automated injection system, Rick earned a Bachelor of Science degree in Microbiology from the University of Arizona, Tucson.

Research Interest

Radiation delivery systems for the treatment of solid cancerous tumors.